Comparison of effectiveness and safety of simvastatin in patients <75 versus > or =75 years of age with coronary, cerebral, or peripheral arterial disease.
Robinson
Jennifer G
JG
Iowa Heart Center, Des Moines, Iowa City, Iowa 50314, USA. jrobinson@iowaheart.com
Conroy
Cynthia
C
Wickemeyer
William J
WJ
D000367:Age Factors; D000368:Aged; D002539:Cerebral Arterial Diseases / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D003324:Coronary Artery Disease / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D012449:Safety; D019821:Simvastatin / Q000627:therapeutic use*; D016019:Survival Analysis; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D019821:Simvastatin